Institute of Cancer and Genomic Sciences Using fundamental research and the power of genomics to develop better therapies in cancer and other complex diseases.
News Researchers find the cause of a metabolic disease. New study demonstrates that loss of autophagy enzymes in respiring cells causes a metabolic deficit and cell death due to depletion of NAD.
03 January 2020 Study finds new non-invasive technique to assess brain tumours in children and make treatment less toxic Ground-breaking research by the University of Birmingham has discovered a new technique to assess the aggressiveness of childhood brain tumours.
04 December 2019 Young women in UK face unnecessary surgery for suspected appendicitis Thousands of young women are unnecessarily admitted to UK hospitals and undergo surgery they do not need each year in the NHS, a new study reveals.
25 October 2019 Leading neurosurgeon highlights importance of brain tumour research Professor Colin Watts, Chair of the Birmingham Brain Cancer Program, highlights the importance of brain tumour research.
25 September 2019 Anti-malarial drug can make cancer chemotherapy more effective Scientists at the University of Birmingham have found an anti-malarial drug was effective in treating head and neck cancer in mice.
14 September 2019 Birmingham researcher awarded 1st prize for oral presentation at prestigious annual scientific meeting Monica Nafria, PhD student in the Institute of Cancer and Genomic Sciences, has been awarded 1st prize for best oral presentation at the International Society for Experimental Haematology annual meeting.
27 August 2019 Removing cancer's protective barrier could boost immunotherapy treatments University of Birmingham scientists may have found a way to pull down the protective wall that surrounds tumours, potentially re-exposing them to the killing power of the immune system and immunotherapy treatments.
07 August 2019 Birmingham collaboration awarded international MRC Newton Fund prostrate cancer grant An international team from the University of Birmingham and the University of Nottingham in the UK and the Kenya Medical Research Institute in Nairobi, Kenya, has been awarded £660,000 to study prostate cancer.
07 August 2019 Three Birmingham scientists awarded £4 million by Cancer Research UK Three researchers from the University of Birmingham have been awarded more than £4 million by Cancer Research UK for their work to investigate new personalised cancer treatments.
01 August 2019 Hidden chemistry in flowers shown to kill cancer cells Researchers at the University of Birmingham have shown that it's possible to produce a compound with anti-cancer properties directly from feverfew – a common flowering garden plant.
24 July 2019 Leading population geneticist is appointed Junior Group Leader The Institute of Cancer and Genomic Sciences recently appointed Dr Marc Haber as Junior Group Leader. He joins Birmingham from the Wellcome Sanger Institute bringing with him extensive experience in population genetics.
19 July 2019 Second Birmingham Symposium on Genome Structure and Function - 4th - 5th July 2019 Second Birmingham Symposium on Genome Structure and Function - 4th to 5th July 2019, Birmingham Centre for Genome Biology
15 July 2019 Cancer researchers discover important first step for personalised head and neck cancer treatment Research led by the University of Birmingham has discovered an important first step in the pathway for developing personalised medicine for the treatment of head and neck cancer.